These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 37782699)
1. DNMT1-mediated regulating on FBXO32 promotes the progression of glioma cells through the regulation of SKP1 activity. Quan J; Ma C Environ Toxicol; 2024 Feb; 39(2):783-793. PubMed ID: 37782699 [TBL] [Abstract][Full Text] [Related]
2. DNMT1-mediated epigenetic suppression of FBXO32 expression promoting cyclin dependent kinase 9 (CDK9) survival and esophageal cancer cell growth. Song XQ; Chen BB; Jin YM; Wang CY Cell Cycle; 2024 Feb; 23(3):262-278. PubMed ID: 38597826 [TBL] [Abstract][Full Text] [Related]
3. FBXO32 suppresses breast cancer tumorigenesis through targeting KLF4 to proteasomal degradation. Zhou H; Liu Y; Zhu R; Ding F; Wan Y; Li Y; Liu Z Oncogene; 2017 Jun; 36(23):3312-3321. PubMed ID: 28068319 [TBL] [Abstract][Full Text] [Related]
4. Promoter hypermethylation of FBXO32, a novel TGF-beta/SMAD4 target gene and tumor suppressor, is associated with poor prognosis in human ovarian cancer. Chou JL; Su HY; Chen LY; Liao YP; Hartman-Frey C; Lai YH; Yang HW; Deatherage DE; Kuo CT; Huang YW; Yan PS; Hsiao SH; Tai CK; Lin HJ; Davuluri RV; Chao TK; Nephew KP; Huang TH; Lai HC; Chan MW Lab Invest; 2010 Mar; 90(3):414-25. PubMed ID: 20065949 [TBL] [Abstract][Full Text] [Related]
5. Repression of Dok7 expression mediated by DNMT1 promotes glioma cells proliferation. Hua CD; Bian EB; Chen EF; Yang ZH; Tang F; Wang HL; Zhao B Biomed Pharmacother; 2018 Oct; 106():678-685. PubMed ID: 29990858 [TBL] [Abstract][Full Text] [Related]
6. STUB1-mediated K63-linked ubiquitination of UHRF1 promotes the progression of cholangiocarcinoma by maintaining DNA hypermethylation of PLA2G2A. Chen J; Wang D; Wu G; Xiong F; Liu W; Wang Q; Kuai Y; Huang W; Qi Y; Wang B; Chen Y J Exp Clin Cancer Res; 2024 Sep; 43(1):260. PubMed ID: 39267107 [TBL] [Abstract][Full Text] [Related]
7. FBXO32 promotes microenvironment underlying epithelial-mesenchymal transition via CtBP1 during tumour metastasis and brain development. Sahu SK; Tiwari N; Pataskar A; Zhuang Y; Borisova M; Diken M; Strand S; Beli P; Tiwari VK Nat Commun; 2017 Nov; 8(1):1523. PubMed ID: 29142217 [TBL] [Abstract][Full Text] [Related]
8. The atypical ubiquitin ligase RNF31 stabilizes c-Myc via epigenetic inactivation of FBXO32 and promotes cancer development. Chen Z; Ren D; Lv J; Xu Y; Xie M; He X; Shi W; Qian Q; Jing A; Ma X; Qin J; Ding Y; Geng T; Ma J; Liu W; Liu S; Ji J Cell Signal; 2023 Jul; 107():110677. PubMed ID: 37028779 [TBL] [Abstract][Full Text] [Related]
9. E3 ubiquitin ligase RNF180 prevents excessive PCDH10 methylation to suppress the proliferation and metastasis of gastric cancer cells by promoting ubiquitination of DNMT1. Zhang N; Gao X; Yuan Q; Fu X; Wang P; Cai F; Liu H; Zhang J; Liang H; Nie Y; Deng J Clin Epigenetics; 2023 May; 15(1):77. PubMed ID: 37147733 [TBL] [Abstract][Full Text] [Related]
10. Downregulation of BASP1 Promotes Temozolomide Resistance in Gliomas via Epigenetic Activation of the FBXO32/NF-κB/MGMT Axis. Liao X; Li Z; Zheng H; Qian W; Zhang S; Chen S; Li X; Tang M; Xu Y; Yu R; Li M; Song L; Li J Mol Cancer Res; 2023 Jul; 21(7):648-663. PubMed ID: 36961398 [TBL] [Abstract][Full Text] [Related]
11. Aberrant methylation and decreased expression of the TGF-β/Smad target gene FBXO32 in esophageal squamous cell carcinoma. Guo W; Zhang M; Shen S; Guo Y; Kuang G; Yang Z; Dong Z Cancer; 2014 Aug; 120(16):2412-23. PubMed ID: 24798237 [TBL] [Abstract][Full Text] [Related]
12. Stratifin Inhibits SCF Shiba-Ishii A; Hong J; Hirokawa T; Kim Y; Nakagawa T; Sakashita S; Sakamoto N; Kozuma Y; Sato Y; Noguchi M Clin Cancer Res; 2019 May; 25(9):2809-2820. PubMed ID: 30728155 [TBL] [Abstract][Full Text] [Related]
13. FBXO32 Targets c-Myc for Proteasomal Degradation and Inhibits c-Myc Activity. Mei Z; Zhang D; Hu B; Wang J; Shen X; Xiao W J Biol Chem; 2015 Jun; 290(26):16202-14. PubMed ID: 25944903 [TBL] [Abstract][Full Text] [Related]
14. DNMT1 mediates chemosensitivity by reducing methylation of miRNA-20a promoter in glioma cells. Zhou D; Wan Y; Xie D; Wang Y; Wei J; Yan Q; Lu P; Mo L; Xie J; Yang S; Qi X Exp Mol Med; 2015 Sep; 47(9):e182. PubMed ID: 26337869 [TBL] [Abstract][Full Text] [Related]
16. FBXO32 targets PHPT1 for ubiquitination to regulate the growth of EGFR mutant lung cancer. Zhang N; Liao Y; Lv W; Zhu S; Qiu Y; Chen N; Xiao M; Zhang H Cell Oncol (Dordr); 2022 Apr; 45(2):293-307. PubMed ID: 35411430 [TBL] [Abstract][Full Text] [Related]
17. DNMT1 Mediated CAHM Repression Promotes Glioma Invasion via SPAK/JNK Pathway. Xu Y; Li Z; Huai T; Huo X; Wang H; Bian E; Zhao B Cell Mol Neurobiol; 2022 Nov; 42(8):2643-2653. PubMed ID: 34227028 [TBL] [Abstract][Full Text] [Related]
18. Genetically engineered mouse models for functional studies of SKP1-CUL1-F-box-protein (SCF) E3 ubiquitin ligases. Zhou W; Wei W; Sun Y Cell Res; 2013 May; 23(5):599-619. PubMed ID: 23528706 [TBL] [Abstract][Full Text] [Related]
19. Regulation of human glioma cell apoptosis and invasion by miR-152-3p through targeting DNMT1 and regulating NF2 : MiR-152-3p regulate glioma cell apoptosis and invasion. Sun J; Tian X; Zhang J; Huang Y; Lin X; Chen L; Zhang S J Exp Clin Cancer Res; 2017 Aug; 36(1):100. PubMed ID: 28764788 [TBL] [Abstract][Full Text] [Related]